PMI Investors Urged to Join Picard Medical Securities Fraud Lawsuit

The Schall Law Firm reminds investors of the opportunity to lead the class action lawsuit against Picard Medical, Inc.

Published on Feb. 5, 2026

Got story updates? Submit your updates here. ›

The Schall Law Firm, a national shareholder rights litigation firm, is reminding investors of a class action lawsuit against Picard Medical, Inc. (NYSE American: PMI) for alleged violations of federal securities laws. The lawsuit covers the period from September 2, 2025 to October 31, 2025, during which the company is accused of making false and misleading statements to the market as part of a manipulation scheme to fraudulently boost its share price.

Why it matters

This lawsuit represents an opportunity for PMI investors who suffered losses to potentially recover damages from Picard Medical and its insiders, who are accused of dumping shares at artificially inflated prices. The case highlights concerns about securities fraud and the importance of shareholder rights litigation in holding public companies accountable.

The details

According to the complaint, Picard Medical engaged in a manipulation scheme designed to fraudulently boost its share price. The company and its insiders are then alleged to have dumped shares at these artificially inflated prices, causing losses for investors when the truth about the company came to light.

  • The class period covers September 2, 2025 to October 31, 2025.
  • Investors have until April 3, 2026 to join the class action lawsuit.

The players

Picard Medical, Inc.

A publicly traded medical device company listed on the NYSE American exchange under the ticker symbol PMI.

The Schall Law Firm

A national shareholder rights litigation firm representing investors in securities class action lawsuits.

Got photos? Submit your photos here. ›

What they’re saying

“We encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge.”

— Brian Schall, Attorney, The Schall Law Firm (PRNewswire)

What’s next

The judge will decide on April 3, 2026 whether to certify the class in this securities fraud lawsuit against Picard Medical.

The takeaway

This case highlights the importance of shareholder rights litigation in holding public companies accountable for alleged securities fraud. PMI investors who suffered losses have an opportunity to potentially recover damages by joining the class action lawsuit against Picard Medical before the April 3rd deadline.